Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)

Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)

Post-marketing surveillance to investigate the clinical safety and effectiveness in patients of all implantation of Gliadel with malignant glioma in the actual medical setting.

Inclusion criteria:

• All-patient of Gliadel implantation

Exclusion criteria:

• None